Naltrexone in the Treatment of Dissociative Symptoms in Patients With Borderline Personality Disorder: An Open-Label Trial
The DOI matches its Crossref record.
Abstract
BACKGROUND: Dissociative phenomena, including flashbacks, are common in patients with borderline personality disorder and posttraumatic stress disorder (PTSD). Although dissociative symptoms can be severe and may interfere with psychotherapy, there is no established pharmacotherapy for these symptoms. Evidence suggests that alterations of the endogenous opiate system contribute to dissociative symptoms in patients with borderline personality disorder and PTSD. METHOD: We treated 2 groups of female borderline personality disorder patients (N = 13, with an overlap of 5 patients between the 2 groups; all met the diagnostic criteria of DSM-IV and the revised Diagnostic Interview for Borderline Patients) who experienced prominent dissociative phenomena including flashbacks with the nonselective opiate receptor antagonist naltrexone, 25 to 100 mg q.i.d., for at least 2 weeks. A self-rated questionnaire measuring dissociation, analgesia, tonic immobility, and tension (DAISS) was applied to 9 patients, who completed it for 7 consecutive days before and during treatment with naltrexone. In addition, 9 patients (with an overlap of 5 patients from the other group) completed a flashback protocol. RESULTS: DAISS scores reflected a highly significant reduction of the duration and the intensity of dissociative phenomena and tonic immobility as well as a marked reduction in analgesia during treatment with naltrexone. Six of 9 patients reported a decrease in the mean number of flashbacks per day. CONCLUSION: These observations support the hypothesis that an increased activity of the opioid system contributes to dissociative symptoms, including flashbacks, in borderline personality disorder and suggest that these symptoms may respond to treatment with opiate antagonists. In view of these results, a placebo-controlled, double-blind study to assess the potential benefit of naltrexone in a more rigorous way appears justified.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Longitudinal and case series studies of naltrexone and nalmefene in depersonalization disorder, borderline personality disorder, and PTSD also support opioid antagonist administration for reduced dissociative symptoms [116–119].”
From Treatment of dissociative identity disorder: leveraging neurobiology to optimize success (2024) · cites this paper as [117]
In the citing paper
“Finally, a handful of studies report successful reductions in dissociative symptoms, including depersonalization, following treatment with opioid-receptor antagonists (e.g., naloxone and naltrexone) among individuals with depersonalization disorder (Nuller et al., 2001;Simeon and Knutelska, 2005), and BPD (Bohus et al., 1999;Schmahl et al., 2012; but see Philipsen et al., 2004).”
From A review of the relation between dissociation, memory, executive functioning and social cognition in military members and civilians with neuropsychiatric conditions (2016) · cites this paper as Bohus et al., 1999
Citations
Cites
Still being checked.
Cited by
Borderline personality disorder
Lieb, K., Zanarini, M. C., Schmahl, C., Linehan, M. M., & Bohus, M. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16770-6 · Cited by 1,369
Self-citationKatzman, M. A., Bleau, P., Blier, P., Chokka, P., Kjernisted, K., Van Ameringen, M., & the Canadian Anxiety Guidelines Initiative Group on behalf of the Anxiety Disorders Association of Canada/Association Canadienne des troubles anxieux and McGill University (2014) · BMC Psychiatry · doi:10.1186/1471-244x-14-s1-s1 · Cited by 1,090
Association Between Mental Health Disorders, Problem Drug Use, and Regular Prescription Opioid Use
Sullivan, M. D., Edlund, M. J., Zhang, L., Unützer, J., & Wells, K. B. (2006) · Archives of Internal Medicine · doi:10.1001/archinte.166.19.2087 · Cited by 434
Forbes, D., Creamer, M., Phelps, A., Bryant, R., McFarlane, A., Devilly, G. J., Matthews, L., Raphael, B., Doran, C., Merlin, T., et al. (2007) · Australian & New Zealand Journal of Psychiatry · doi:10.1080/00048670701449161 · Cited by 335
Pharmacological interventions for borderline personality disorder
Stoffers, J., Völlm, B. A., Rücker, G., Timmer, A., Huband, N., & Lieb, K. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005653.pub2 · Cited by 302
The Interpersonal Dimension of Borderline Personality Disorder: Toward a Neuropeptide Model
Stanley, B., & Siever, L. J. (2010) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2009.09050744 · Cited by 289
Bohus, M., Limberger, M., Ebner, U., Glocker, F. X., Schwarz, B., Wernz, M., & Lieb, K. (2000) · Psychiatry Research · doi:10.1016/s0165-1781(00)00179-7 · Cited by 270
Self-citationVermetten, E., & Bremner, J. D. (2002) · Depression and Anxiety · doi:10.1002/da.10017 · Cited by 210
Depersonalisation Disorder: A Contemporary Overview
Simeon, D. (2004) · CNS Drugs · doi:10.2165/00023210-200418060-00002 · Cited by 198
Neurobiology of posttraumatic stress disorder
Newport, D. (2000) · Current Opinion in Neurobiology · doi:10.1016/s0959-4388(00)00080-5 · Cited by 190
Stiglmayr, C. E., Shapiro, D. A., Stieglitz, R. D., Limberger, M. F., & Bohus, M. (2001) · Journal of Psychiatric Research · doi:10.1016/s0022-3956(01)00012-7 · Cited by 172
Self-citationDysregulation of Regional Endogenous Opioid Function in Borderline Personality Disorder
Prossin, A. R., Love, T. M., Koeppe, R. A., Zubieta, J.-K., & Silk, K. R. (2010) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2010.09091348 · Cited by 167
Endogenous opioids and nonsuicidal self-injury: A mechanism of affect regulation
Bresin, K., & Gordon, K. H. (2013) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2013.01.020 · Cited by 193
Pharmacological interventions for people with borderline personality disorder
Binks, C., Fenton, M., McCarthy, L., Lee, T., Adams, C. E., & Duggan, C. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005653 · Cited by 143
Borderline personality disorder: a dysregulation of the endogenous opioid system?
Bandelow, B., Schmahl, C., Falkai, P., & Wedekind, D. (2010) · Psychological Review · doi:10.1037/a0018095 · Cited by 135
Self-citationRecent Advances in the Biological Study of Personality Disorders
New, A. S., Goodman, M. S., Triebwasser, J., & Siever, L. J. (2008) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2008.03.011 · Cited by 138
Loew, T. H., Nickel, M. K., Muehlbacher, M., Kaplan, P., Nickel, C., Kettler, C., Fartacek, R., Lahmann, C., Buschmann, W., Tritt, K., et al. (2006) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000195113.61291.48 · Cited by 129
Altered central μ-opioid receptor binding after psychological trauma
Liberzon, I., Taylor, S. F., Phan, K. L., Britton, J. C., Fig, L. M., Bueller, J. A., Koeppe, R. A., & Zubieta, J.-K. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.06.021 · Cited by 118
Complex Trauma in Adolescents and Adults
Briere, J., & Scott, C. (2015) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2015.05.004 · Cited by 114
Brand, B. L., Lanius, R., Vermetten, E., Loewenstein, R. J., & Spiegel, D. (2012) · Journal of Trauma & Dissociation · doi:10.1080/15299732.2011.620687 · Cited by 114
Pharmacotherapy for Borderline Personality Disorder—Current Evidence and Recent Trends
Stoffers‐Winterling, J., & Lieb, K. (2014) · Current Psychiatry Reports · doi:10.1007/s11920-014-0534-0 · Cited by 130
Colasanti, A., Rabiner, E., Lingford-Hughes, A., & Nutt, D. (2011) · Journal of Psychopharmacology · doi:10.1177/0269881110367726 · Cited by 107
Impulsive aggression in borderline personality disorder
Goodman, M. S., & New, A. S. (2000) · Current Psychiatry Reports · doi:10.1007/s11920-000-0043-1 · Cited by 108
Mula, M., Pini, S., & Cassano, G. B. (2007) · Journal of Affective Disorders · doi:10.1016/j.jad.2006.08.025 · Cited by 100
McKinnon, M. C., Boyd, J. E., Frewen, P. A., Lanius, U. F., Jetly, R., Richardson, J. D., & Lanius, R. A. (2016) · Neuropsychologia · doi:10.1016/j.neuropsychologia.2016.07.017 · Cited by 94
“Indeed, among individuals with BPD, pretreatment dissociative symptomatology predicted reduced symptom improvement following treatment with dialectical behavioural therapy (Kleindienst et al., 2011).”
InfluentialUnderstanding and treating depersonalisation disorder
Medford, N., Sierra, M., Baker, D., & David, A. S. (2005) · Advances in Psychiatric Treatment · doi:10.1192/apt.11.2.92 · Cited by 93
Saper, J. R., & Lake, A. E. (2002) · Headache: The Journal of Head and Face Pain · doi:10.1046/j.1526-4610.2002.02156.x · Cited by 89
Dissociation and borderline personality disorder: An update for clinicians
Korzekwa, M. I., Dell, P. F., & Pain, C. (2009) · Current Psychiatry Reports · doi:10.1007/s11920-009-0013-1 · Cited by 85
Mu Opioid Receptor Antagonists: Recent Developments
Goodman, A. J., Bourdonnec, B. L., & Dolle, R. E. (2007) · ChemMedChem · doi:10.1002/cmdc.200700143 · Cited by 84
Evidence-based pharmacotherapy for personality disorders
Ripoll, L. H., Triebwasser, J., & Siever, L. J. (2011) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145711000071 · Cited by 83
“1996) and dissociation (Bohus et al. 1999).”
MethodAn Open Trial of Naltrexone in the Treatment of Depersonalization Disorder
Simeon, D., & Knutelska, M. (2005) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000162803.61700.4f · Cited by 80
Posttraumatic Stress Disorder Revisited
Lamprecht, F., & Sack, M. (2002) · Psychosomatic Medicine · doi:10.1097/00006842-200203000-00005 · Cited by 76
Review of treatments for severe personality disorder
Warren, F. C., Preedy-Fayers, K., McGauley, G., Pickering, A. D., Norton, K., & Dolan, B. M. (2003) · Cited by 80
Timäus, C., Meiser, M., Bandelow, B., Engel, K., Paschke, A. M., Wiltfang, J., & Wedekind, D. (2019) · BMC Psychiatry · doi:10.1186/s12888-019-2377-z · Cited by 74
Comprehensive Inpatient Treatment of Refractory Chronic Daily Headache
Lake, A. E., Saper, J. R., & Hamel, R. L. (2009) · Headache: The Journal of Head and Face Pain · doi:10.1111/j.1526-4610.2009.01364.x · Cited by 66
Depersonalization disorder: pharmacological approaches
Sierra, M. (2008) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.8.1.19 · Cited by 62
Opioids:From Physical Pain to the Pain of Social Isolation
Stein, D. J., van Honk, J., Ipser, J., Solms, M., & Panksepp, J. (2007) · CNS Spectrums · doi:10.1017/s1092852900021490 · Cited by 62
Psychopharmacologic treatment of borderline personality disorder
Ripoll, L. H. (2013) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2013.15.2/lripoll · Cited by 54
Relationship of Personality to Dissociation and Childhood Trauma in Borderline Personality Disorder
Simeon, D., Nelson, D., Elias, R., Greenberg, J., & Hollander, E. (2003) · CNS Spectrums · doi:10.1017/s109285290001912x · Cited by 52
“Different classes of medications may better target dissociative symptoms (eg, opioid antagonists).(10) Psychotherapeutically, the presence of prominent dissociation may dictate the need for additional interventions, such as trauma-focused work, refocusing and grounding techniques,(11) or greater emphasis on reducing p…”
Diseth, T. H., & Christie, H. J. (2005) · Nordic Journal of Psychiatry · doi:10.1080/08039480500213683 · Cited by 67
Kolla, N. J., Eisenberg, H., & Links, P. S. (2008) · Archives of Suicide Research · doi:10.1080/13811110701542010 · Cited by 46
Magerl, W., Burkart, D., Fernandez, A., Schmidt, L. G., & Treede, R.-D. (2012) · Pain · doi:10.1016/j.pain.2011.11.021 · Cited by 43
Huemer, J., Erhart, F., & Steiner, H. (2010) · Child Psychiatry & Human Development · doi:10.1007/s10578-010-0192-3 · Cited by 42
Pharmacotherapy for dissociative disorders: A systematic review
Sutar, R., & Sahu, S. (2019) · Psychiatry Research · doi:10.1016/j.psychres.2019.112529 · Cited by 42
Borderline Personality Disorder Features and Risk for Prescription Opioid Use Disorders
Tragesser, S. L., Jones, R. E., Robinson, R. J., Stutler, A., & Stewart, A. (2013) · Journal of Personality Disorders · doi:10.1521/pedi_2013_27_094 · Cited by 41
Torres‐Berrío, A., & Nava-Mesa, M. O. (2018) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2018.08.011 · Cited by 46
Possible role of a dysregulation of the endogenous opioid system in antisocial personality disorder
Bandelow, B., & Wedekind, D. (2015) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.2497 · Cited by 41
Pain experience related to self-injury in eating disorder patients
Claes, L., Vandereycken, W., & Vertommen, H. (2005) · Eating Behaviors · doi:10.1016/j.eatbeh.2005.09.003 · Cited by 37
Lubin, G., Weizman, A., Shmushkevitz, M., & Valevski, A. (2002) · Human Psychopharmacology: Clinical and Experimental · doi:10.1002/hup.395 · Cited by 37
Psychopathologie und Therapie der Borderline-Persönlichkeitsstörung
Bohus, M., & Schmahl, C. G. (2007) · Der Nervenarzt · doi:10.1007/s00115-007-2341-x · Cited by 66
Self-citationReutens, S. G., Nielsen, O., & Sachdev, P. S. (2010) · Current Opinion in Psychiatry · doi:10.1097/yco.0b013e3283387ab4 · Cited by 37
Aliyev, N. A., & Aliyev, Z. N. (2011) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e31820428e1 · Cited by 28
RetractedBorderline Personality Disorder
Emanuele, J. M., & Muehlenkamp, J. J. (2011) · Springer eBooks · doi:10.1007/978-1-4419-1695-2_83 · Cited by 27
Neurobiology of Posttraumatic Stress Disorder
Newport, D. J., & Nemeroff, C. B. (2003) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/foc.1.3.313 · Cited by 29
Personality and Personality Disorders
Blais, M. A., Smallwood, P., Groves, J. E., & Rivas-Vazquez, R. A. (2008) · Elsevier eBooks · doi:10.1016/b978-0-323-04743-2.50041-x · Cited by 24
Current Clinical Psychopharmacology in Borderline Personality Disorder
CASALE, A. D., Bonanni, L., Bargagna, P., Novelli, F., Fiaschè, F., Paolini, M., Forcina, F., Anibaldi, G., Cortese, F. N., Iannuccelli, A., et al. (2021) · Current Neuropharmacology · doi:10.2174/1570159x19666210610092958 · Cited by 34
Pharmacotherapy of personality disorders
Triebwasser, J., & Siever, L. J. (2007) · Journal of Mental Health · doi:10.1080/09638230601182078 · Cited by 26
Off-label use of atypical antipsychotics in personality disorders
Rosenbluth, M. J., & Sinyor, M. (2011) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2011.608351 · Cited by 26
A neural network model of Borderline Personality Disorder
Berdahl, C. (2009) · Neural Networks · doi:10.1016/j.neunet.2009.10.007 · Cited by 25
Drug Treatment of Personality Disorder Traits
Reich, J. H. (2002) · Psychiatric Annals · doi:10.3928/0048-5713-20021001-07 · Cited by 19
Pharmacotherapy for personality disorders
Newton‐Howes, G., & Tyrer, P. J. (2003) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.4.10.1643 · Cited by 23
Treatment of dissociative identity disorder: leveraging neurobiology to optimize success
Purcell, J. B., Brand, B., Browne, H. A., Chefetz, R. A., Shanahan, M., Bair, Z. A., Baranowski, K. A., Davis, V., Mangones, P., Modell, R. L., et al. (2024) · Expert review of neurotherapeutics · doi:10.1080/14737175.2024.2316153 · Cited by 18
The Treatment of Depersonalization-Derealization Disorder: A Systematic Review
Wang, S., Zheng, S., Zhang, X., Ma, R., Feng, S., Song, M., Zhu, H., & Jia, H. (2023) · Journal of Trauma & Dissociation · doi:10.1080/15299732.2023.2231920 · Cited by 25
Niedrig dosiertes Naltrexon in der Behandlung dissoziativer Symptome
Pape, W., & Wöller, W. (2015) · Der Nervenarzt · doi:10.1007/s00115-014-4015-9 · Cited by 17
Efficacy of naltrexone in borderline personality disorder, a retrospective analysis in inpatients
Timäus, C., Meiser, M., Wiltfang, J., Bandelow, B., & Wedekind, D. (2021) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.2800 · Cited by 17
Anpassungsstörung, akute und posttraumatische Belastungsstörung
Kapfhammer, H. (2003) · Springer eBooks · doi:10.1007/3-540-27386-7_54 · Cited by 19
“Are You Talking to Me?” Confronting Behavioral Disturbances in Patients With Headache
Saper, J. R. (2006) · Headache The Journal of Head and Face Pain · doi:10.1111/j.1526-4610.2006.00569.x · Cited by 14
Pain-determined Dissociation Episodes
Fishbain, D. A., Cutler, R. B., Rosomoff, H., & Rosomoff, R. S. (2001) · Pain Medicine · doi:10.1046/j.1526-4637.2001.01034.x · Cited by 15
Trauma and Dissociation: Treatment Perspectives
Kreidler, M. C., Zupancic, M. K., Bell, C., & Longo, M. B. (2009) · Perspectives In Psychiatric Care · doi:10.1111/j.1744-6163.2000.tb00697.x · Cited by 13
Borderline Personality, Opioids, and Naltroxone
Saper, J. R. (2000) · Headache The Journal of Head and Face Pain · doi:10.1046/j.1526-4610.2000.00137-1.x · Cited by 14
[Cross-cultural adaptation and validation of the Cambridge Depersonalisation Scale].
Castillo, J. J. M., de la Iglesia, J. M., Colomer, C. A., Berríos, G. E., Sierra, M., & Luque, R. L. (2006) · Actas Españolas de Psiquiatría · Cited by 19
The Difficult Patient: Borderline Personality Disorder in the Obstetrical and Gynecological Patient
Ricke, A. K., Lee, M., & Chambers, J. E. (2012) · Obstetrical & Gynecological Survey · doi:10.1097/ogx.0b013e318267f1db · Cited by 14
Kapfhammer, H. (2014) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2014.16.2/hkapfhammer · Cited by 15
Stress, Opioid Peptides, and Their Receptors
Przewłocki, R. (2009) · Elsevier eBooks · doi:10.1016/b978-008088783-8.00008-5 · Cited by 14
Psychopharmacologic Management of Suicidality in Personality Disorders
Cardish, R. J. (2007) · The Canadian Journal of Psychiatry · doi:10.1177/07067437070526s110 · Cited by 15
Treatment of dissociative symptoms with opioid antagonists: a systematic review
Escamilla, I., Juan, N., Peñalva, C., Sánchez-Llorens, M., Renau, J., Benito, A., & Haro, G. (2023) · European Journal of Psychotraumatology · doi:10.1080/20008066.2023.2265184 · Cited by 15
Mason, T., Caulfield, M., Hall, R., & Melling, K. (2010) · Issues in Mental Health Nursing · doi:10.3109/01612840903398727 · Cited by 11
The Potential Role of Naltrexone in Borderline Personality Disorder.
Moghaddas, A., Dianatkhah, M., Ghaffari, S., & Ghaeli, P. (2017) · PubMed Central · Cited by 15
Psychopharmacologic Treatment of Patients With Borderline Personality Disorder
Grossman, R. (2002) · Psychiatric Annals · doi:10.3928/0048-5713-20020601-10 · Cited by 11
Medications in the treatment of borderline personality disorder 2006
Mercer, D. (2007) · Current Psychiatry Reports · doi:10.1007/s11920-007-0010-1 · Cited by 10
Chronic Daily Headache: A Clinician's Perspective
Saper, J. R. (2002) · Headache The Journal of Head and Face Pain · doi:10.1046/j.1526-4610.2002.04263.x · Cited by 9
Bremner, J. D., Williamson, D., & Vaccarino, V. (2024) · Journal of Affective Disorders · doi:10.1016/j.jad.2024.08.050 · Cited by 9
Borderline personality disorder - a dysregulation of the endogenous opioid system?
Bandelow, B., Schmahl, C. G., Falkai, P., & Wedekind, D. (2011) · European Psychiatry · doi:10.1016/s0924-9338(11)72713-4 · Cited by 8
Self-citationStress, Opioid Peptides, and Their Receptors
Przewłocki, R. (2002) · Elsevier eBooks · doi:10.1016/b978-012532104-4/50014-7 · Cited by 10
Treating Symptoms of Borderline Personality Disorder Through Narrative Therapy and Naltrexone
Tadros, E., Cappetto, M., & Kaur, L. (2019) · American Journal of Family Therapy · doi:10.1080/01926187.2019.1590787 · Cited by 9
Posttraumatische Belastungsstörung, Anpassungsstörungen und Selbstbeschädigungserkrankungen
Brunner, R. M., Plener, P. L., & Resch, F. (2011) · Springer eBooks · doi:10.1007/978-3-642-19846-5_21 · Cited by 9
Pharmacologic treatment of personality disorders.
Rivas-Vazquez, R. A., & Blais, M. A. (2002) · Professional Psychology Research and Practice · doi:10.1037/0735-7028.33.1.104 · Cited by 7
Recent evidence-based developments in the treatment of DID
Bachrach, N., & Huntjens, R. J. C. (2025) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2025.1650164 · Cited by 11
Prunetti, E., Bosio, V., Bateni, M., & Liotti, G. (2012) · Psychology and Psychotherapy Theory Research and Practice · doi:10.1111/j.2044-8341.2011.02060.x · Cited by 7
Evidence-based pharmacotherapy of personality disorders
Ripoll, L. H., Triebwasser, J., & Siever, L. J. (2012) · Cambridge University Press eBooks · doi:10.1017/cbo9780511910395.015 · Cited by 6
"Late-Onset" Borderline Personality Disorder: A Life Unraveling
Bernstein, M. E., Reich, D. B., Zanarini, M. C., & Siever, L. J. (2002) · Harvard Review of Psychiatry · doi:10.1080/hrp.10.5.292.301 · Cited by 6
Pharmakologische und psycho- therapeutische Behandlung der Borderline-Störung
Remmel, A., & Bohus, M. (2006) · Zeitschrift für Psychiatrie Psychologie und Psychotherapie · doi:10.1024/1661-4747.54.3.185 · Cited by 11
Self-citationNeurobiologische Grundlagen von psychotherapeutischen Interventionen
Bohus, M., Mauchnik, J., & Schmahl, C. G. (2009) · Zeitschrift für Psychiatrie Psychologie und Psychotherapie · doi:10.1024/1661-4747.57.2.97 · Cited by 7
Self-citationCounterpoint: Clinical neuroscience is not ready for clinical use
Rego, M. D. (2016) · The British Journal of Psychiatry · doi:10.1192/bjp.bp.115.170878 · Cited by 6
Approche thérapeutique des troubles dissociatifs
Damsa, C., Pirrotta, R., Adam, E., Hyams, H., Lazignac, C., & Ducrocq, F. (2005) · Annales Médico-psychologiques revue psychiatrique · doi:10.1016/j.amp.2005.09.023 · Cited by 5
Pain Perception in Psychiatric Disorders
Lautenbacher, S., & Hemmeter-Spernal, J. (2004) · Springer eBooks · doi:10.1007/978-1-4419-9068-6_12 · Cited by 5
Adult ADHD in Trauma- and Stressor-Related Disorders
Pallanti, S., & Salerno, L. (2020) · Springer eBooks · doi:10.1007/978-3-030-39051-8_13 · Cited by 4
Przewłocki, R., & Almeida, O. F. X. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-803592-4.00008-0 · Cited by 5
Gainer, D. M., Crawford, T. N., Fischer, K. B., & Wright, M. D. (2020) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2020.108195 · Cited by 4
Priebe, K., & Schmahl, C. G. (2008) · Psychiatrie und Psychotherapie up2date · doi:10.1055/s-2008-1067345 · Cited by 3
Self-citation
Metadata
- Authors
- Bohus, M. J., Landwehrmeyer, G. B., Stiglmayr, C. E., Limberger, M. F., Böhme, R., & Schmahl, C. G.
- Affiliations
- University of Freiburg (DE)
- Venue
- The Journal of Clinical Psychiatry
- Publisher
- Physicians Postgraduate Press, Inc
- Published
- 1999-09-15
- Volume
- 60
- Issue
- 9
- Pages
- 598-603
- ISSN
- 0160-6689 (ISSN-L)
- OpenAlex
- W1990256375
- Cited by
- 153
- References
- 0
- Citations by year
- 2025: 1 · 2024: 6 · 2023: 4 · 2022: 1 · 2021: 3 · 2020: 4 · 2019: 7 · 2018: 2 · 2017: 3 · 2016: 4 · 2015: 4 · 2014: 6 · 2013: 8 · 2012: 6
- FWCI
- 8.57
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- FreiDok plus (Universitätsbibliothek Freiburg) (submittedVersion)
- Topics
- Social Sciences › Psychology › Clinical Psychology › Personality Disorders and Psychopathology
- Health Sciences › Medicine › Psychiatry and Mental health › Psychosomatic Disorders and Their Treatments
- Social Sciences › Psychology › Clinical Psychology › Psychoanalysis and Psychopathology Research
- Keywords
- naltrexone, borderline personality disorder, dissociative symptoms, flashbacks, post-traumatic stress disorder, opioid system, opioid antagonists, tonic immobility, analgesia, dissociation
- MeSH terms
- Adolescent, Adult, Borderline Personality Disorder, Dissociative Disorders, Dose-Response Relationship, Drug, Drug Administration Schedule, Female, Germany, Humans, Middle Aged, Naltrexone, Narcotic Antagonists, Personality Inventory, Psychiatric Status Rating Scales, Severity of Illness Index, Comorbidity, Treatment Outcome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.